Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 31, 2015
Grant Date -
Oct 24, 2013
app pub date -
Jan 9, 2012
filing date -
Jan 11, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to a combination of syrosingopine and a mitochondrial inhibitor, e.g. metformin or oligomycin, and the use of the combination of syrosingopine and a mitochondrial inhibitor for the treatment of cancer and for achieving immunosuppression. The invention also relates to a fluorescence-based method for predicting syrosingopine sensitivity of a cancer cell.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully